O câncer é uma das maiores causas de mortalidade no Brasil e no mundo, com potencial de crescimento nas próximas décadas. Um tipo de tratamento promissor é a hipertermia magnética, procedimento no qual as células tumorais morrem pelo efeito do calor gerado por partículas magnéticas após a aplicação de campo magnético alternado em frequências adequadas. Tais partículas também são capazes de atuar como agentes de contraste para imageamento por ressonância magnética, um poderoso método de diagnóstico para identificação de células neoplásicas, formando a combinação conhecida como theranostics (terapia e diagnóstico). Neste trabalho foram sintetizadas nanopartículas de óxido de ferro por método de coprecipitação com posterior encapsulação por técnica de nano spray drying, visando sua aplicação no tratamento de câncer por hipertermia e como agente de contraste para imageamento por ressonância magnética. Para a encapsulação foram utilizadas matrizes poliméricas de Maltodextrina com Polissorbato 80, Pluronic F68, Eudragit® S100 e PCL com Pluronic F68, escolhidos com o intuito de formar partículas que dispersem bem em meio aquoso e que consigam atingir alvo tumoral após administração no corpo do paciente. Parâmetros de secagem pelo equipamento Nano Spray Dryer, como temperatura, solvente e concentração de reagentes, foram avaliados. As partículas formadas foram caracterizadas por Microscopia Eletrônica de Varredura, Difração de Raios-X, Análise Termogravimétrica, Espalhamento de Luz Dinâmico, Espectroscopia de Infravermelho, magnetismo quanto a magnetização de saturação e temperatura, citotoxicidade e potencial de aquecimento. Tais procedimentos indicaram que o método de coprecipitação produziu nanopartículas de magnetita de tamanho em torno 20 nm, superparamagnéticas a temperatura ambiente, sem potencial citotóxico. A técnica de nano spray drying foi eficiente para a formação de partículas com tamanho em torno de 1 &#956m, também superparamagnéticas, biocompatíveis e com propriedades magnéticas adequadas e para aplicações pretendidas. Destaca-se a amostra com Pluronic, OF-10/15-1P, que apresentou magnetização de saturação de 68,7 emu/g e interação específica com células tumorais. / Cancer is one of the greatest causes of mortality in Brazil and in the world, with growing potential for the next decades. A promising treatment alternative is magnetic hyperthermia, in which tumor cells die by the heat generated by magnetic nanoparticles after application of an alternate magnetic field in adequate frequencies. Such particles are also capable of acting as contrast agents for magnetic resonance imaging, a powerful method of diagnosis for the identification of neoplasic cells, which characterizes the combination of properties known as theranostics (therapy and diagnosis). In this work, iron oxide nanoparticles were synthesized by coprecipitation method with subsequent encapsulation by nano spray drying technique, aiming their application on cancer treatment by hyperthermia and on magnetic resonance imaging as a contrast agent. Polymeric matrices of Maltodextrin with Polysorbate 80, Pluronic F68, Eudragit® S100 and PCL with Pluronic F68 were employed for encapsulation, chosen carefully to create particles that disperse well in aqueous media and that are able to address the tumoral target after administration into the patient\'s body. Drying parameters of the Nano Spray Dryer equipment, such as temperature, dispersing medium and reagent concentrations, were evaluated. The generated particles were characterized by Scanning Electron Microscopy, X-Ray Diffraction, Thermogravimetric Analysis, Dynamic Light Scattering, Infrared Spectroscopy, by magnetism in matters of applied magnetic field and temperature, cytotoxic potential and heating potential. Such methods indicated that the coprecipitation method was able to produce magnetite nanoparticles with size of approximately 20 nm, superparamagnetic at room temperature and with no cytotoxic potential. The nano spray drying technique was efficient to produce particles with size of around 1 &#956m, biocompatible, superparamagnetic and with adequate magnetic properties for the intended applications. The sample OF-10/15-1P stands out with a saturation magnetization of 68.7 emu/g and presenting specific interactions with the tumour cells.

O câncer é uma das maiores causas de mortalidade no Brasil e no mundo, com potencial de crescimento nas próximas décadas. Um tipo de tratamento promissor é a hipertermia magnética, procedimento no qual as células tumorais morrem pelo efeito do calor gerado por partículas magnéticas após a aplicação de campo magnético alternado em frequências adequadas. Tais partículas também são capazes de atuar como agentes de contraste para imageamento por ressonância magnética, um poderoso método de diagnóstico para identificação de células neoplásicas, formando a combinação conhecida como theranostics (terapia e diagnóstico). Neste trabalho foram sintetizadas nanopartículas de óxido de ferro por método de coprecipitação com posterior encapsulação por técnica de nano spray drying, visando sua aplicação no tratamento de câncer por hipertermia e como agente de contraste para imageamento por ressonância magnética. Para a encapsulação foram utilizadas matrizes poliméricas de Maltodextrina com Polissorbato 80, Pluronic F68, Eudragit® S100 e PCL com Pluronic F68, escolhidos com o intuito de formar partículas que dispersem bem em meio aquoso e que consigam atingir alvo tumoral após administração no corpo do paciente. Parâmetros de secagem pelo equipamento Nano Spray Dryer, como temperatura, solvente e concentração de reagentes, foram avaliados. As partículas formadas foram caracterizadas por Microscopia Eletrônica de Varredura, Difração de Raios-X, Análise Termogravimétrica, Espalhamento de Luz Dinâmico, Espectroscopia de Infravermelho, magnetismo quanto a magnetização de saturação e temperatura, citotoxicidade e potencial de aquecimento. Tais procedimentos indicaram que o método de coprecipitação produziu nanopartículas de magnetita de tamanho em torno 20 nm, superparamagnéticas a temperatura ambiente, sem potencial citotóxico. A técnica de nano spray drying foi eficiente para a formação de partículas com tamanho em torno de 1 &#956m, também superparamagnéticas, biocompatíveis e com propriedades magnéticas adequadas e para aplicações pretendidas. Destaca-se a amostra com Pluronic, OF-10/15-1P, que apresentou magnetização de saturação de 68,7 emu/g e interação específica com células tumorais. / Cancer is one of the greatest causes of mortality in Brazil and in the world, with growing potential for the next decades. A promising treatment alternative is magnetic hyperthermia, in which tumor cells die by the heat generated by magnetic nanoparticles after application of an alternate magnetic field in adequate frequencies. Such particles are also capable of acting as contrast agents for magnetic resonance imaging, a powerful method of diagnosis for the identification of neoplasic cells, which characterizes the combination of properties known as theranostics (therapy and diagnosis). In this work, iron oxide nanoparticles were synthesized by coprecipitation method with subsequent encapsulation by nano spray drying technique, aiming their application on cancer treatment by hyperthermia and on magnetic resonance imaging as a contrast agent. Polymeric matrices of Maltodextrin with Polysorbate 80, Pluronic F68, Eudragit® S100 and PCL with Pluronic F68 were employed for encapsulation, chosen carefully to create particles that disperse well in aqueous media and that are able to address the tumoral target after administration into the patient\'s body. Drying parameters of the Nano Spray Dryer equipment, such as temperature, dispersing medium and reagent concentrations, were evaluated. The generated particles were characterized by Scanning Electron Microscopy, X-Ray Diffraction, Thermogravimetric Analysis, Dynamic Light Scattering, Infrared Spectroscopy, by magnetism in matters of applied magnetic field and temperature, cytotoxic potential and heating potential. Such methods indicated that the coprecipitation method was able to produce magnetite nanoparticles with size of approximately 20 nm, superparamagnetic at room temperature and with no cytotoxic potential. The nano spray drying technique was efficient to produce particles with size of around 1 &#956m, biocompatible, superparamagnetic and with adequate magnetic properties for the intended applications. The sample OF-10/15-1P stands out with a saturation magnetization of 68.7 emu/g and presenting specific interactions with the tumour cells.

Radionuclide production is always the first step of radiopharmaceutical research. The production of n.c.a.197Hg together with the short-lived 197mHg isomer is possible by proton or deuteron irradiation of natural gold using a cyclotron, as two promising nuclear reactions reported: 197Au(p,n)197(m)Hg reaction, 197Au(d,2n)197(m)Hg reaction. The access to n.c.a. 197(m)Hg should be in sufficient quantity and quality so as to be suitable for analytical studies and labeling studies with small scale and for animal and other preclinical studies on large scale. Moreover, an improved design by studying irradiation time and energy will provide the facility with sufficient quantity and quality for imaging and experimental therapeutically purposes. The development of a rapid, reliable method for Hg/Au separation represents an important prerequisite for increasing yields which will obtain 197(m)Hg in higher activity level with the product elution into a small volume. Here, many of previously established methods for mercury separation should be employed, such as distillation of the metal, extraction by organic solvents, extraction by resin, etc. However, owing to the different mechanisms, these separations do not always give satisfactory results. The purity and the final volume of product, efficiency, automatization and total processing time of separation procedure, these factors are extremely important for the next coming labeling studies. Therefore, comparison studies need to be employed to select the most suitable method enable for labeling studies. Establishing strategies for development of 197(m)Hg labeled in vivo stable labeling units. Several ready-to-use chelators are urgent needed before 197(m)Hg labeling unit conjugated with any specific targeted molecules. Numerous factors need to be considered for the development of the agents: Firstly, a robust synthetic and labeling strategy should be developed for the chelators or precursors of 197(m)Hg. Secondly, it should be strongly stable (especially bio-stability) to avoid the accumulation of radioactive substances in non-target organs. Thirdly, water solubility should be high enough for animal administration and avoid the toxicity of organic solvent. Fourthly, high selectivity (specificity) to avoid the transchelation/side reaction(s) with other metal ions. There are mainly two different approaches for 197(m)Hg labeling, first kind of ligands are based on Hg-S bonds, which form 197(m)Hg-S based compounds. It is well known that mercury shows strong ability on chelating of thiols, dithiols, disulfide, sulfur based and other sulfur rich interacting ligands, which shows great potentials for 197(m)Hg labeling. Thus, thiol based chelators should be investigated in the thesis. 197(m)Hg-organometallics was the second. Mercury is unique among metals in its capability to form covalent Hg-C bonds and has its own organic chemistry because the existence of large numbers of organic Hg compounds, which shows great potential to be labeled and applied in the field of radiopharmacy. After synthesizing novel agents, its theranostics capability should be accessed by a series of in vitro and in vivo studies. Depending on the type of different agents, the radiolabeling strategies should be optimized. Soon afterwards, detailed analytical and in vitro characterization with high-performance liquid chromatography (HPLC), radio thin-layer chromatography (radio-TLC), among other methods should be performed to determine several radiochemical behaviors such as labeling efficiency and stability. Besides, for the purpose of in vivo animal studies, removal of organic solvents and well-suited methods for purification of the radiolabeled units should be developed if necessary. Then, the most promising radiolabeled compounds were selected for further pharmacokinetic studies in rats. In vivo SPECT imaging studies should be employed for further investigations of radiopharmacological behaviors.

The majority of pharmacologically active chemotherapeutics are poorly water soluble. Solubilization enhancement by the utilization of organic solvents often leads to adverse side effects. Nanoparticle-based cancer therapy, which is passively targeted to the tumor tissue via the enhanced permeation and retention effect, has been vastly developed in recent years. Nanocrystals, which exist as crystalline and carry nearly 100% drug loading, has been explored for delivering antineoplastic agents. Additionally, the hybrid nanocrystal concept offers a novel and simple way to integrate imaging agents into the drug crystals, enabling the achievement of theranostics. The overall objective of this dissertation is to formulate both pure and hybrid nanocrystals, evaluate their performance in vitro and in vivo, and investigate the extent of tissue distribution and tumor accumulation in a murine model. Pure and hybrid nanocrystals of several model drugs, including paclitaxel (PTX), camptothecin, and ZSTK474, were precipitated by the antisolvent method in the absence of stabilizer, and their size was further minimized by homogenization. The nanocrystals of PTX, which is the focus of the study, had particle size of approximately 200 nm and close-to-neutral surface charge. Depending on the cell type, PTX nanocrystals exerted different level of cytotoxicity. In human colon and breast cancer xenograft models, nanocrystals yielded similar efficacy as the conventional formulation, Taxol, at a dose of 20 mg/kg, yet induced a reduced toxicity. Biodistribution study revealed that 3H-PTX nanocrystals were sequestered rapidly by the macrophages upon intravenous injection. Yet, apparent toxicity was not observed even after four weekly injections. The sequestered nanocrystals were postulated to be released slowly into the blood circulation and reached the tumor. Tritium-labeled-taxol, in contrast, was distributed extensively to all the major organs, inducing systemic toxicity as observed in significant body weight loss. The biodistribution results obtained from radioactive analysis and whole-body optical imaging was compared. To some degree, the correlation was present, but divergence in the quantitative result, due to nanocrystal integrity and limitations associated with the optical modality, existed. Despite their promising properties, nanocrystal suspensions must be securely stabilized by stealth polymers in order to minimize opsonization, extend blood-circulation time, and efficiently target the tumor.

Personalized medicine can be an approach to address the unsatisfactory treatment outcomes in inflammatory conditions such as cancer, arthritis, and cardiovascular diseases. A common feature of chronic diseases is the infiltration of pro-inflammatory macrophages at the disease loci. Infiltrating macrophages have been previously utilized for disease diagnosis. These features suggest that macrophages can be broadly applicable targets for simultaneous therapy and diagnosis. Cyclooxygenase-2 (COX-2), an enzyme involved in the biosynthesis of a lipid inflammatory mediator, prostaglandin E2 (PGE2), is over expressed in macrophages infiltrating the pathological site. Inhibition of PGE2 leads to reduced inflammation, pain and macrophage infiltration. To utilize macrophages for the purpose of simultaneous therapy and diagnosis, we proposed to integrate therapeutic and imaging capabilities on a single nanomedicine platform, referred as theranostics. A stable 19F MRI visible nanoemulsion platform was developed, incorporating celecoxib for COX-2 inhibition and near-infrared fluorescent dye(s) for fluorescence imaging. We hypothesized that inhibition of COX-2 in macrophages using a theranostic nanoemulsion will reduce the inflammation (and pain), and that this response can be visualized by monitoring changes in macrophage infiltration. In vitro characterization demonstrated that the theranostic displays excellent stability with no toxicity, and significant uptake in macrophages. Furthermore, it delivers celecoxib to macrophages and reduces PGE2 production from these cells. In vivo studies in a murine paw inflammation model showed nanoemulsion presence at the inflamed site, specifically in COX-2 expressing macrophages compared to neutrophils. Supporting our hypothesis, celecoxib delivered through a nanoemulsion demonstrated time-dependent reduction in fluorescence from the inflamed paw, indicative of reduced macrophage infiltration. In a neuropathic pain model, celecoxib delivered to macrophages led to reduced pain concomitant with reduced macrophage infiltration at the inflamed site compared to free drug control (cross reference: Kiran Vasudeva, Dissertation, 2015). In conclusion, inhibition of COX-2 in macrophages using theranostic nanoemulsions proves to be an effective and generalized strategy facilitating simultaneous therapy and diagnosis, which can be applied to many chronic diseases. The diagnostic information during therapy can be used to tailor the treatment and reduce patient variability leading to personalized medicine. / Mylan School of Pharmacy and the Graduate School of Pharmaceutical Sciences; / Pharmaceutics / PhD; / Dissertation;

Cette thèse s’inscrit dans le développement et l’évaluation de nouvelles plateformesmoléculaires pour une application en imagerie optique par fluorescence. Nous avons cherché àdévelopper de nouveaux outils multifonctionnels et modifiables à façon. Cette approche estnécessaire car l’introduction d’un fluorophore peut fortement influencer les propriétés ducomposé final. Cela signifie que l’introduction du fluorophore sur l’agent sélectionné doit avoirêtre réalisé dès le départ. Pour cela deux axes principaux ont été étudiés; le premier consiste àutiliser des BODIPY pour le développement d’agents thérapeutiques traçables pour uneapplication principalement in vitro; le deuxième cible sur la conception de plateformes à based’AzaBODIPY compatibles avec l’imagerie in vivo.Dans la première partie deux fluorophores à base de 3,5-dichloro-BODIPY ont été identifiéscomme plateformes prometteurs. Ils ont été fonctionnalisés sélectivement par un agent or(I)-phosphine, un thiosucre et un phosphonium afin de pouvoir étudier l’influence du positionnementde chaque substituant sur les propriétés finales. Nous avons pu démontrer qu’unefonctionnalisation sélective et spécifique est possible avec ces substituants fragiles ; cela nous apermis de développer 12 agents théranostiques à base d’or(I). Les propriétés photophysiques etbiologiques ont ensuite été évaluées; pour cela nous avons déterminé leurs propriétés antiprolifératives (3 lignés cellulaires), la balance hydrophile, l’accumulation d’or dans les cellules etla localisation des composés des composés par microscopie confocale. Cette stratégie deplateforme multifonctionnelle nous a permis de développer un panel de composés traçables ayantdes activités mixtes ainsi que des distributions cellulaires distinctes. Cette étude a permisl’identification et la sélection de trois ou quatre composés qui feront l’objet d’une étudeapprofondie.Dans la deuxième partie de cette thèse nous avons développé des plateformes multifonctionnellescompatibles avec l’imagerie in vivo; pour cela nous avons poursuivi deux approches différentes.La première était l’utilisation de 1,7-di(phenol)3,5-di(phenyl)-azaBODIPY, suivi par safonctionnalisation sur les groupements OH afin de développer un traceur bioconjugablefluorescent dans le proche infrarouge (NIR-I). Malheureusement ce traceur possède despropriétés optiques très défavorables. Nous avons alors développé une approche innovante baséesur la fonctionnalisation de l’atome de bore. En s’appuyant sur cette approche deux traceursfortement fluorescents dans le proche infrarouge et solubles dans l’eau ont été développés. Cesfluorophores ont été conjugués sur un anticorps innovateur afin de permettre l’imagerie optiquedu ligand PD-L1. Les traceurs se sont montrés stables pour au moins 48h dans le plasma murin etpossèdent de très bonnes propriétés optiques. Comme preuve de concept nous avons conduitune étude préclinique in vivo. Cette étude a montré que les traceurs sont fortement fluorescents(NIR-I) et ne possèdent pas de toxicité imminente.La méthodologie développée pendant cette thèse présente un grand potentiel pour des étudesallant plus loin et des futures applications ; il est possible d’appliquer les principes et outilsdéveloppés sur d’autre fluorophores ; la méthodologie permet une fonctionnalisation très richeavec une grande variété de substituants d’intérêt. Son utilisation n’est pas limitée aux applicationsbiologiques, biochimiques et médicinales. / The objective of this thesis was the development and evaluation of new molecular platformsfor optical fluorescence imaging applications. This work sought to develop new tools that caneasily be modified and adapted to the specific needs of the intended use. This is required asthe fluorophore will influence the final properties and should thus be incorporated beforestructural optimization of the selected agent rather than at the very end. Two main axes wereexplored; the use of BODIPYs for the development of trackable therapeutic agents that areprimarily intended for in vitro applications and the use of azaBODIPYs for the design of an invivo compatible fluorescent platform.In the first part two fluorophores on the basis of a 3,5-dichloro-BODIPY were identified aspromising platforms. These platform molecules were selectively functionalized using a gold(I)-phosphine moiety, a thiosugar and a phosphonium to explore their selective functionalizationand investigate the influence of each substitutents position on the final properties. Weshowed that a site-specific, selective functionalization with these fragile substituents ispossible and developed 12 gold(I)-bearing therapeutic agents. We evaluated thephotophysical properties of all obtained compounds which was followed by a characterizationof their biological properties (antiproliferative properties on 3 cancer cell lines, lipophilicbalance and cellular gold accumulation as well as fluorescence imaging on 3 cell lines for upto 24h). We succeeded in developing a panel of closely related trackable compounds thatdisplay mixed activity in cells and distinct cellular localization. This investigation permitted theselection of three to four hits that will be studied further.In the second part we developed an in vivo-compatible multifunctional platform following twostrategies: the first was the use of 1,7-di(phenol)-3,5-di(phenyl)-azaBODIPY and thefunctionalization of the hydroxy groups for the development of a bioconjugable NIR-I probe.Unfortunately the developed probe displayed very unfavourable optical properties; wetherefore developed a new strategy that is entirely based on the functionalization of the boronatom. Using this approach we successfully synthesized 2 watersoluble, strongly fluorescent(NIR-I) molecular platforms that were conjugated to an innovative antibody to image the PD-L1 ligand. The developed probes displayed excellent optical properties, are stable for at least48h in mice plasma and were validated in a preclinical study on mice. The developed probesdisplayed strong fluorescence in vivo and showed no acute toxicity.The developed methodology shows great potential for further investigations and futurestudies; it can be transposed onto other closely related fluorophores and permits versatilefunctionalization with a large variety of compounds of interest. Its use is thus not limited tobiological, biochemical and medical applications.

Ovarian cancer, one of the most dreadful malignancies of the female reproductive system, poses a lethal threat to women worldwide. In this dissertation, the objective was to introduce a novel type of graphene quantum dots (GQDs) based nano-sized drug delivery systems (DDS) for ovarian cancer treatment. As a starting point, the facile synthesis method of the GQDs was established. Subsequently, the targeting ligand,folic acid (FA), was conjugated to GQDs. Next, a FDA approved chemotherapeutic drug, Doxorubicin (DOX), was loaded to form the GQDs-FA-DOX nano-conjugation as the DDS. Moreover, the uptake profile and anti-cancer effect of the GQDs-FA-DOX were validated in ovarian cancer cells. Finally, the immunotoxicity of GQDs and its mechanism were investigated and elucidated. Taken together, the findings described in this dissertation provide a novel and powerful strategy of targeted treatment for ovarian cancer.

Carbon dots (CDs) have attracted much attention as an excellent gene/drug delivery and biological imaging agent for early cancer theranostics. In this study, we prepared two series of nanoparticles (NPs), which are composed of (CDs) with a targeting agent, folic acid (FA), and a chemotherapeutic agent Doxorubicin (Dox). All the NPs and their intermediates were characterized using ultraviolet-visible spectroscopy (UV-vis), fluorescence spectroscopy, and Fourier transform-infrared spectroscopy (FT-IR). The drug loading capacity (DLC) and drug loading efficiency (DLE) of two series of FA-CDs-Dox were assessed using UV-vis absorption spectroscopy at the wavelength of 485 nm. Both showed good DLE and DLC results when compared to literature data. In addition, the cumulative release property of Dox from the FA-CDs-Dox complexes were investigated in a pH solution of 7.4.

The development of therapeutic drugs or drug systems that enhance a cancer patient's quality of life during treatment is a primary goal for many researchers across a wide range of disciplines. Many investigators turn to nanoparticles (~50-200 nm in size) that tend to accumulate in tumor tissues in order to deliver active drug compounds to specific sites in the body. This targeted delivery approach would reduce the total body effects of current cancer drugs that result in unwanted (sometimes painful and even fatal) side effects. One of the main obstacles however, is ensuring that drugs incorporated into the nanoparticles are anchored such that premature drug release is prohibited. Also, while it is important to ensure strong drug-nanocarrier interactions, the nanocarrier must be able to release the drug when it has reached its biological target. We have developed a nanocarrier that provides a platform for drug systems that could achieve this drug release via the use of a light "trigger". Metal-Organic Frameworks (MOFs) are a relatively new class of often highly porous materials that act as "sponges" for the absorption of various small molecules. MOFs are so named because they consist of metal clusters that are linked by organic compounds to form networked solids that are easily tuned based on the choice of metal and organic "linker". We have developed a MOF nanocarrier incorporating benign zirconium (IV) metal clusters bridged by an organic component that changes shape when illuminated with a light source. The resulting material is therefore not stable upon irradiation due to the organic linker shape change that disturbs the MOF structure and causes it to degrade. When loaded with drugs, this photo-enhanced degradation results in the release of the cargo thereby, providing a handle on controlling drug release with the use of a light trigger. We have demonstrated that in the presence of the MOF nanocarrier incorporating 5-fluorouracil (a clinically available cancer drug), very low toxicity to human breast cancer cells is observed in the dark, however, cell death occurs in the presence of a light source. These reports offer a model MOF nanocarrier system that could be used to incorporate various drugs and therefore tune the system to an individual patient's needs. Furthermore, we also developed a material that is capable of providing magnetic resonance imaging (MRI) contrast by changing the metal to manganese (II). MRI contrast agents are compounds that serve to either darken or brighten an MRI image based on the agent used and therefore they aid in clinical diagnosis by making internal abnormalities easier to spot. Currently gadolinium (III) complexes are the most widely used contrast agents; however, the toxicity of gadolinium (III) has been shown to be responsible for the development of nephrogenic systemic fibrosis in some patients. This manganese material has also shown useful for the attachment of fluorescent dyes that can aid in the benchtop optical diagnosis of biopsies. These reports provide a basis for developing ways to offer controlled drug delivery in cancer patients and to aid in cancer diagnosis using MOF materials, in an effort to reach the goals of comfortable cancer treatment. / Ph. D.

Les nanoparticules de silice sont très largement étudiées pour les applications biomédicales. Elles permettent une facilité et une flexibilité de la synthèse des particules et une bio-toxicité limitée. Cette thèse a mené une grande diversité de résultats impliquant des nanomatériaux de silice. Premièrement, les propriétés physicochimiques et les propriétés de biodégradation de trois types de nanoparticules de silice structurées ont été étudiées dans un tampon, un milieu de culture et au contact de fibroblastes cutanés humains suggérant que les nanoparticules de silice doivent être principalement considérées comme dégradées par hydrolyse, et non biodégradé. Ensuite, des nanoparticules de silice multifonctionnelles constituées de nanoparticules de silice creuses et de nanoparticules de MnO2 ont été synthétisées. Ainsi le contrôle de la libération du médicament et la performance de l’imagerie de ces nanoplates ont été étudiées à partir de modèles 2D à 3D. Cette approche pourrait être utilisée pour une évaluation rapide de la bio-fonctionnalité des nanoparticules avant de mettre en place des expériences in vivo. En outre, un nouveau nanocomposite 3D à base de collagène utilisant des tiges de silice a été étudié et les relations entre la composition composite, la structure et les propriétés mécaniques, mettant en évidence le rôle clé des interactions collagène-silice. L'influence de ces paramètres sur l'adhésion et la prolifération des cellules fibroblastiques a également été étudiée. De plus, nous avons préparé et utilisé des nanobatonnêts de silice magnétiques pour contrôler l’orientation des particules dans le réseau de collagène grâce à un champ magnétique externe. Tous les résultats apportent de nouvelles connaissances sur la préparation et les propriétés des bionanocomposites et ouvrent la voie à des hydrogels multifonctionnels. / Silica nanoparticles, thanks to the great easy and adaptability of particle synthesis and limited biotoxicity, is very widely studied for biomedical applications. This thesis conducted a large diversity of investigations involving silica nanomaterials. Firstly, the physicochemical properties and biodegradation properties of three types of structured silica nanoparticles were studied in a buffer, a culture medium and in contact with human dermal fibroblasts that suggest that, under these conditions, the silica nanoparticles must be mainly considered as degraded by hydrolysis and not biodegraded. Then, multifunctional silica nanoparticles which are consist of hollow silica nanoparticles and MnO2 nanosheets were synthesized. And the control drug release and imaging performance of this nanoplatforms were studied from 2D to 3D models. This approach could be used for a rapid assessment of the biofunctionality of nanoparticles before setting up in vivo experiments. Furthermore, a new 3D collagen-based nanocomposites using silica rods were studied and the relationships between the composite composition, structure and mechanical properties, emphasizing the key role of collagen-silica interactions. The influence of these parameters on the adhesion and proliferation of fibroblast cells was also investigated. In addition, we prepared and used magnetic silica nanorods to control particle orientation within the collagen network thanks to an external magnetic field. All the results bring new insights on the preparation and properties of bionanocomposites and open the route to multifunctional hydrogels.